03/06/2024 4:56 PM | IDEXX Laboratories (Subject) POLEWACZYK JAMES F (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 4:36 PM | IDEXX Laboratories (Subject) Vandebroek Sophie V. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/22/2024 3:17 PM | IDEXX Laboratories (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/16/2024 4:54 PM | Erickson Michael G (Reporting) IDEXX Laboratories (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 4:55 PM | FENNELL GEORGE (Reporting) IDEXX Laboratories (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 4:55 PM | Hunt Nimrata (Reporting) IDEXX Laboratories (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 4:56 PM | IDEXX Laboratories (Issuer) Johnson Michael Perkins (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
02/16/2024 4:56 PM | IDEXX Laboratories (Issuer) Lane Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 4:56 PM | IDEXX Laboratories (Issuer) MAZELSKY JONATHAN JAY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 4:57 PM | IDEXX Laboratories (Issuer) MCKEON BRIAN P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 4:57 PM | IDEXX Laboratories (Issuer) POLEWACZYK JAMES F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 4:58 PM | IDEXX Laboratories (Issuer) Schreck Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 4:58 PM | IDEXX Laboratories (Issuer) Smith Martin Alexander (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 4:58 PM | IDEXX Laboratories (Issuer) Underberg Sharon E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 4:01 PM | IDEXX Laboratories (Issuer) MCKEON BRIAN P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 4:02 PM | AYERS JONATHAN W (Reporting) IDEXX Laboratories (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 4:03 PM | FENNELL GEORGE (Reporting) IDEXX Laboratories (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 4:26 PM | FENNELL GEORGE (Reporting) IDEXX Laboratories (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/07/2024 6:01 PM | IDEXX Laboratories (Subject) MAZELSKY JONATHAN JAY (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/07/2024 5:17 PM | IDEXX Laboratories (Subject) MCKEON BRIAN P (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2024 5:30 AM | IDEXX Laboratories (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/01/2024 4:00 PM | IDEXX Laboratories (Issuer) JUNIUS DANIEL M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/24/2024 8:46 AM | BlackRock Inc. (Filed by) IDEXX Laboratories (Subject)
| Form SC 13G/A | |
01/05/2024 4:01 PM | FENNELL GEORGE (Reporting) IDEXX Laboratories (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/05/2024 4:02 PM | IDEXX Laboratories (Issuer) Schreck Michael (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/08/2023 4:00 PM | IDEXX Laboratories (Issuer) POLEWACZYK JAMES F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/07/2023 4:01 PM | IDEXX Laboratories (Subject) POLEWACZYK JAMES F (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023 4:01 PM | IDEXX Laboratories (Issuer) MAZELSKY JONATHAN JAY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/01/2023 4:00 PM | AYERS JONATHAN W (Reporting) IDEXX Laboratories (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2023 5:50 PM | AYERS JONATHAN W (Reporting) IDEXX Laboratories (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/08/2023 4:09 PM | IDEXX Laboratories (Issuer) Lane Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/01/2023 5:06 PM | IDEXX Laboratories (Issuer) JUNIUS DANIEL M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/01/2023 3:20 PM | IDEXX Laboratories (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/01/2023 5:30 AM | IDEXX Laboratories (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/06/2023 4:00 PM | Britt Irene Chang (Reporting) IDEXX Laboratories (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/06/2023 4:01 PM | IDEXX Laboratories (Issuer) Smith Martin Alexander (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/31/2023 5:02 PM | IDEXX Laboratories (Subject) MAZELSKY JONATHAN JAY (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/31/2023 4:17 PM | IDEXX Laboratories (Issuer) POLEWACZYK JAMES F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/29/2023 4:25 PM | IDEXX Laboratories (Subject) POLEWACZYK JAMES F (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/17/2023 6:37 PM | AYERS JONATHAN W (Reporting) IDEXX Laboratories (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2023 4:59 PM | IDEXX Laboratories (Issuer) MAZELSKY JONATHAN JAY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
The only AI company you should be looking at (Ad) This is the ONLY AI company you should be watching right now.
No. It's not Nvidia, Intel, or Microsoft...
It's a tiny biotech using proprietary AI to assist in new drug discovery at a rate 100,000 times faster than a human.
This new drug discovery technique will change the market.
And that's why they received a $50 million investment from an AI powerhouse. Get the stock ticker here >>> |
08/08/2023 4:59 PM | IDEXX Laboratories (Issuer) MCKEON BRIAN P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/03/2023 4:57 PM | IDEXX Laboratories (Subject) Lane Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2023 4:19 PM | IDEXX Laboratories (Issuer) JUNIUS DANIEL M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/01/2023 5:30 AM | IDEXX Laboratories (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/12/2023 4:00 PM | Britt Irene Chang (Reporting) IDEXX Laboratories (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
07/12/2023 6:01 AM | IDEXX Laboratories (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/18/2023 6:55 PM | AYERS JONATHAN W (Reporting) IDEXX Laboratories (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2023 5:43 PM | IDEXX Laboratories (Subject) Turner Kathy V (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2023 4:31 PM | AYERS JONATHAN W (Reporting) IDEXX Laboratories (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2023 4:31 PM | COLLINS Asha (Reporting) IDEXX Laboratories (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2023 4:31 PM | ESSIG STUART (Reporting) IDEXX Laboratories (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2023 4:32 PM | IDEXX Laboratories (Issuer) Kingsley Lawrence D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2023 4:32 PM | IDEXX Laboratories (Issuer) SZOSTAK M ANNE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2023 4:32 PM | IDEXX Laboratories (Issuer) Vandebroek Sophie V. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/11/2023 4:01 PM | AYERS JONATHAN W (Reporting) IDEXX Laboratories (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2023 6:20 PM | IDEXX Laboratories (Subject) Turner Kathy V (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/05/2023 5:00 PM | IDEXX Laboratories (Issuer) MAZELSKY JONATHAN JAY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/05/2023 5:01 PM | IDEXX Laboratories (Issuer) Vandebroek Sophie V. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/05/2023 4:38 PM | IDEXX Laboratories (Subject) Lane Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/05/2023 3:53 PM | IDEXX Laboratories (Subject) SZOSTAK M ANNE (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/04/2023 4:57 PM | IDEXX Laboratories (Subject) Vandebroek Sophie V. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2023 5:01 PM | IDEXX Laboratories (Issuer) JUNIUS DANIEL M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2023 5:34 AM | IDEXX Laboratories (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |